Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2
Elevation Oncology
Elevation Oncology
Pfizer
Advaxis, Inc.
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
Karyopharm Therapeutics Inc
Daiichi Sankyo
National Institutes of Health Clinical Center (CC)
Navidea Biopharmaceuticals
National Institutes of Health Clinical Center (CC)
BioVex Limited
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
Eli Lilly and Company